Key regions: United Kingdom, Germany, France, South Korea, Italy
The COVID-19 pandemic has affected the entire world in various ways, including the pharmaceutical industry. Benin, a country in West Africa, has been no exception to this. The COVID-19 Vaccines market in Benin has been developing in a certain way due to customer preferences, local special circumstances, and underlying macroeconomic factors.
Customer preferences: In Benin, the majority of the population is skeptical about vaccines due to religious beliefs and a lack of education on the subject. This has resulted in a slow uptake of vaccines, including the COVID-19 vaccine. However, there is a growing interest in traditional medicine and natural remedies, which has resulted in a demand for alternative treatments for COVID-19.
Trends in the market: The COVID-19 Vaccines market in Benin has been slow to develop due to the low demand for vaccines. However, there has been a growing interest in alternative treatments and natural remedies for COVID-19, which has resulted in a demand for traditional medicine. This has led to the development of a market for traditional medicine, including herbal remedies and other natural treatments.
Local special circumstances: Benin is a low-income country with a weak healthcare system, which has made it difficult to distribute vaccines effectively. The country has also faced challenges with vaccine hesitancy due to a lack of education on the subject and religious beliefs. The government has been working to address these issues by increasing education on vaccines and working with religious leaders to promote vaccination.
Underlying macroeconomic factors: The COVID-19 pandemic has had a significant impact on the economy of Benin, with many people losing their jobs and struggling financially. This has made it difficult for people to afford vaccines, which has contributed to the slow uptake of vaccines. Additionally, the country has faced challenges with vaccine distribution due to a lack of infrastructure and resources.In conclusion, the COVID-19 Vaccines market in Benin has been developing slowly due to a lack of demand for vaccines and a growing interest in alternative treatments. The country's weak healthcare system and low-income status have also contributed to the challenges faced in distributing vaccines. However, the government has been working to address these issues by increasing education on vaccines and promoting vaccination.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
